Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

LRH1 enhances cell resistance to chemotherapy by transcriptionally activating MDC1 expression and attenuating DNA damage in human breast cancer

13 Mar 2018

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA Repair Mechanisms
Share to Epigenetics and DNA Methylation
Share to Genetic factors in colorectal cancer

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 29545602
DOI: 10.1038/s41388-018-0193-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 19 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

LRH1 enhances cell resistance to chemotherapy by transcriptionally activating MDC1 expression and attenuating DNA damage in human breast cancerPMID 29545602Read ↗

MCL-1 plays an oncogenic role in breast cancer by modulating chemoresistance and stemness properties by activating Wnt/β-cateninSemantic proximity Read ↗

HRD1 in human malignant neoplasms: Molecular mechanisms and novel therapeutic strategy for cancerSemantic proximity Read ↗

CHL1 is involved in human breast tumorigenesis and progressionSemantic proximity Read ↗

ALDH1A1 in breast cancer: A prospective target to overcome therapy resistance (Review)Semantic proximity Read ↗

Epigenetic activation of HORMAD1 in basal-like breast cancer: role in Rucaparib sensitivitySemantic proximity Read ↗

MCL-1 plays an oncogenic role in breast cancer by modulating chemoresistance and stemness properties by activating Wnt/β-cateninSemantic proximity Read ↗

PRMT1 regulates EGFR and Wnt signaling pathways and is a promising target for combinatorial treatment of breast cancerSemantic proximity Read ↗

Hpr6 (Heme-1 Domain Protein) Regulates the Susceptibility of Cancer Cells to Chemotherapeutic DrugsSemantic proximity Read ↗

LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapySemantic proximity Read ↗

Targeting DNA repair in breast cancer: A clinical and translational updateSemantic proximity Read ↗

Anticancer drugs: IDH2 drives cancer in vivo.Semantic proximity Read ↗

Aberrant expression of DNA damage response proteins is associated with breast cancer subtype and clinical featuresSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.